CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Genmab A/S Company Snapshot
Genmab A/S operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genmab A/S with three other miscellaneous service companies in Europe: Bachem Holding AG of Switzerland (2017 sales of 261.61 million Swiss Francs [US$260.05 million] of which 88% was Active Pharmaceutical Ingredients), AddLife AB of Sweden (2.33 billion Swedish Kronor [US$256.97 million] of which 60% was LabTech), and Clinigen Group PLC which is based in the United Kingdom (£302.30 million [US$392.09 million] of which 36% was Clinical Trial services).

Sales Analysis. Genmab A/S reported sales of 2.37 billion Danish Kroner (US$359.50 million) for the year ending December of 2017. This represents an increase of 30.2% versus 2016, when the company's sales were 1.82 billion Danish Kroner. Sales at Genmab A/S have increased during each of the previous five years (and since 2012, sales have increased a total of 388%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Genmab A/S
  Stock Performance Chart for Genmab A/S
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 992.40
(Figures in Danish Kroner)
1 Week 2.1%   13 Weeks 7.6%  
4 Weeks -6.2%   52 Weeks -13.6%  
 
Genmab A/S Key Data:
  Ticker: GEN Country: Denmark
  Exchanges: CPH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 2,365,436,000
(Year Ending Jan 2018).
Employees: 257
  Currency: Danish Kroner Market Cap: 60,793,697,563
  Fiscal Yr Ends: December Shares Outstanding: 61,259,268
  Share Type: Stammaktie Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.